Matrix — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Boulder, US
BENJAMIN APEL(Executive Officer, Director, Promoter)ADAM CHERUBINI(Executive Officer, Director, Promoter)LEONARD SPEISER(Director)
Board seatDana Stalder· per SEC Form D · $21.1M raise · filed May 2024
Centaur.ai uses performance-based AI and collective intelligence methods to improve medical decision-making in skin lesion assessment for cancer detection.
AI & Machine LearningData & InfrastructureHealthtechMedical DevicesBoston, US
Erik Duhaime(Founder)inTom Gellatly(Founder)inZach Rausnitz(Founder)in
Co-investorsSBXiY CombinatorAccelAlumni VenturesSamsung NextSignalFire+1 more
Centaur.ai combines human medical professionals' assessments with AI algorithms to improve diagnostic accuracy for skin lesion evaluation and cancer detection.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechMedical Devices
Erik Duhaime
Co-investors186 VenturesAccelAlumni VenturesBasecamp FundOmega Venture PartnersSamsung Next+3 more
Mevo is a Brazilian health platform that offers digital prescription management and online medication ordering and delivery services.
Digital HealthHealthtechSaaS
Co-investorsFloating Point
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.